Cholinergic anti-inflammatory pathway activity in dialysis patients: a role for neuroimmunomodulation?

Hilderman, Marie; Qureshi, Abdul R; Al-Abed, Yousef; Abtahi, Farhad; Lindecrantz, Kaj; Anderstam, Björn; Bruchfeld, Annette

Hilderman, Marie; Qureshi, Abdul R; Al-Abed, Yousef; Abtahi, Farhad; Lindecrantz, Kaj; Anderstam, Björn; Bruchfeld, Annette.

Afiliación

Hilderman M; Renal Medicine and Baxter Novum , CLINTEC, Karolinska Institutet , Stockholm , Sweden.
Qureshi AR; Renal Medicine and Baxter Novum , CLINTEC, Karolinska Institutet , Stockholm , Sweden.
Al-Abed Y; Center for Biomedical Science , Feinstein Institute for Medical Research , Manhasset, NY , USA.
Abtahi F; Royal Institute of Technology , School of Technology and Health , Stockholm , Sweden.
Lindecrantz K; Royal Institute of Technology , School of Technology and Health , Stockholm , Sweden.
Anderstam B; Renal Medicine and Baxter Novum , CLINTEC, Karolinska Institutet , Stockholm , Sweden.
Bruchfeld A; Renal Medicine and Baxter Novum , CLINTEC, Karolinska Institutet , Stockholm , Sweden.

Clin Kidney J ; 8(5): 599-605, 2015 Oct.

Article en En | MEDLINE | ID: mdl-26413288

Palabras clave

autonomic dysfunction; cholinergic agonist; cytokine attenuation; dialysis; inflammation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Kidney J Año: 2015 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google